CHMP recommends EU approval of Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma March 25, 2022March 25, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: Roche’s Polivy combination approved by European…FDA accepts supplemental Biologics License…FDA Advisory Committee votes in favour of the…Roche presents new and updated data for Polivy in…FDA accepts supplemental Biologics License…Five-year results confirm Roche’s Polivy combination…
